InKemia IUCT Group SA (IKM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:InKemia IUCT Group SA (IKM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9437
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InKemia IUCT Group SA (InKemia IUCT), formerly Institut Univ De Ciencia i Technology SA, is a biotechnology company. The company provides research and development, technological, and consulting services. It offers customized research services. InKemia IUCT provides technology services such as physical-chemical analysis and microbiology control services, quality consulting, scientific and technical consultancy, occupational safety and health/environment, and legal auditing services for occupational risk prevention. The company’s technology services also include contract pharmaceutical manufacturing services comprising manufacturing and control services for pharmaceutical products; and active pharmaceutical ingredients production services. The company serves chemical, pharmaceutical, biotechnology, cosmetic, and food and related industries. It operates offices in Mollet del Valles, Tres Cantos and Vilanova i la Geltru, Spain. InKemia IUCT is headquartered in Mollet del Valles, Spain.

InKemia IUCT Group SA (IKM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InKemia IUCT Group SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InKemia IUCT Group SA, Medical Devices Deals, 2012 to YTD 2018 9
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Myogem Health Company May Raise up to USD0.57 Million in Venture Financing 11
Partnerships 12
1nkemia IUCT Forms Joint Venture with Bionos Biotech 12
Equity Offering 13
1nkemia IUCT to Raise USD2.5 Million in Public Offering of Shares 13
InKemia IUCT Completes IPO 14
Acquisition 15
IUCT Empren Sells BioDan Sciences for USD0.2 Million 15
InKemia IUCT Group SA – Key Competitors 16
InKemia IUCT Group SA – Key Employees 17
InKemia IUCT Group SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InKemia IUCT Group SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InKemia IUCT Group SA, Deals By Therapy Area, 2012 to YTD 2018 8
InKemia IUCT Group SA, Medical Devices Deals, 2012 to YTD 2018 9
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Myogem Health Company May Raise up to USD0.57 Million in Venture Financing 11
1nkemia IUCT Forms Joint Venture with Bionos Biotech 12
1nkemia IUCT to Raise USD2.5 Million in Public Offering of Shares 13
InKemia IUCT Completes IPO 14
IUCT Empren Sells BioDan Sciences for USD0.2 Million 15
InKemia IUCT Group SA, Key Competitors 16
InKemia IUCT Group SA, Key Employees 17
InKemia IUCT Group SA, Other Locations 18
InKemia IUCT Group SA, Subsidiaries 18

List of Figures
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InKemia IUCT Group SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[InKemia IUCT Group SA (IKM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • First Republic Bank:企業の戦略・SWOT・財務分析
    First Republic Bank - Strategy, SWOT and Corporate Finance Report Summary First Republic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析
    Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Consumers Energy Company-エネルギー分野:企業M&A・提携分析
    Summary Consumers Energy Company (Consumers), formerly Consumers Power, is an electric and natural gas utility. The company generates purchases, transmits, distributes, and sells electricity. It also carries out the purchase, transmission, storage, distribution, and sale of natural gas. It generates …
  • RainDance Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary RainDance Technologies Inc (RDT), a subsidiary of Bio-Rad Laboratories Inc is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA; …
  • Radiation Monitoring Devices Inc:製品パイプライン分析
    Summary Radiation Monitoring Devices Inc (RMD), a subsidiary of Dynasil Corporation of America is a research and development company that provides solutions for security, medical and industrial applications. The company’s products include scintillators, APDs, cesium iodide, solid state photomultipli …
  • Abreos Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosi …
  • Oracle Financial Services Software Limited (OFSS):企業の財務・戦略的SWOT分析
    Oracle Financial Services Software Limited (OFSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • ActiveCare Inc:医療機器:M&Aディール及び事業提携情報
    Summary ActiveCare Inc (ActiveCare) is a medical equipment company that monitors health analytics. The company provides monitoring component to traditional disease management and wellness solutions. It offers solutions such as diabetes supplies, online web-based administrative tools, browser and iPh …
  • Softrock Minerals Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Softrock Minerals Ltd (Softrock Minerals), formerly Petromax Resources Inc is an oil and gas exploration and development company. The company acquires, explores and develops oil and gas, and mineral deposits. It holds oil and gas producing interests in Alberta. Softrock Minerals also holds m …
  • Ryanair Holdings plc:企業の戦略・SWOT・財務分析
    Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Cedars-Sinai Medical Center:企業のM&A・事業提携・投資動向
    Cedars-Sinai Medical Center - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cedars-Sinai Medical Center Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Balfour Beatty plc:企業の戦略・SWOT・財務情報
    Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report Summary Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cytox Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias and its blood tests are used to predict …
  • McDermott International Inc (MDR):石油・ガス:M&Aディール及び事業提携情報
    Summary McDermott International Inc (MII) is a provider of integrated engineering, procurement, construction and installation (EPCI), front-end engineering and design (FEED) and module fabrication services for upstream field developments. It delivers fixed and floating production facilities, pipelin …
  • Altri SGPS SA (ALTR):企業の財務・戦略的SWOT分析
    Altri SGPS SA (ALTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • DAMAC Real Estate Development Ltd:企業の戦略・SWOT・財務情報
    DAMAC Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report Summary DAMAC Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • National Comprehensive Cancer Network:製薬・医療:M&Aディール及び事業提携情報
    Summary National Comprehensive Cancer Network (NCCN) is a not-for-profit cancer center that offers patient care, research, and education services. The center offers research and medical information to help patients and health professionals related to cancer care. It provides subscriptions and produc …
  • Zh International Holdings Ltd:企業の戦略・SWOT・財務分析
    Zh International Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zh International Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Norwegian Energy Company ASA (NOR):石油・ガス:M&Aディール及び事業提携情報
    Summary Norwegian Energy Company ASA (Noreco) is an oil and gas company that offers exploration and development services. The company explores, produces and develops oil, gas, and natural gas liquids deposit properties. It operates through ongoing and planned exploration wells such as PL616 Haribo a …
  • Marina Portoroz d.d.:企業の戦略・SWOT・財務情報
    Marina Portoroz d.d. - Strategy, SWOT and Corporate Finance Report Summary Marina Portoroz d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆